Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > PharmaNova, Inc. Forms Strategic Alliance With Taiwan-Based Orient Europharma

Abstract:
PharmaNova Inc. today announced that it has formed a strategic alliance and collaboration with Orient Europharma Company Ltd. (Taiwan OTC: 4120) (OEP) of Taiwan, R.O.C. In this two-way relationship, it is intended that OEP will be PharmaNova's exclusive manufacturing and commercialization partner for future PharmaNova products in the core territories of Taiwan, Hong Kong, Singapore, Malaysia, the Philippines and S. Korea served by OEP, and that OEP will manufacture and supply PharmaNova products to future marketing partners in the broader Asia-Pacific region. OEP has an extensive technology base for the controlled release of pharmaceuticals, both orally and by transdermal administration, that is highly complementary to PharmaNova's platform Medisperse(TM) nanoparticle and Surface Enhancement (SET(TM)) technologies.

PharmaNova, Inc. Forms Strategic Alliance With Taiwan-Based Orient Europharma

ROCHESTER, NY | Posted on March 21st, 2007

As part of the arrangement, OEP will address the scale up of the nanoparticle technology and, together, OEP and PharmaNova intend to become world leaders in the application and manufacturing of nanoparticle-based pharmaceuticals. The companies will collaborate on the application of both companies' platform technologies to complete mutually selected new product opportunities, for development and commercialization worldwide utilizing OEP's new manufacturing facilities in Taiwan. PharmaNova President Rodney Brown said, "We are very impressed with OEP's excellent product manufacturing and commercialization capabilities and look forward to a long and mutually rewarding relationship."

OEP has an extensive portfolio of products both in development and already in the marketplace, and PharmaNova will support OEP in expanding the regional commercialization of its products throughout Asia-Pacific and through partnerships in Latin America, Europe and U.S. Central to the collaboration is the exclusive development and commercialization of Xenolev-CR(TM) by OEP for Asia Pacific territories. Xenolev-CR(TM) is PharmaNova's proprietary non-hormonal treatment for hot flashes associated with the menopause and other conditions. Mr. Peter Tsai, president and chairman of OEP, said, "We are very excited about this partnership with PharmaNova as it will allow OEP to expand the geographical scope of our business activities beyond the immediate Asia Pacific region by contributing our expertise in product development and utilizing our new state of the art manufacturing facilities."

####

About PharmaNova, Inc.
PharmaNova Inc. ( ' http://www.pharmanovaco.com ' ) is a privately held, specialty drug development company founded on the re-purposing and enhancement of known drugs using proprietary Medisperse(TM) nanoparticle and other formulation technologies. PharmaNova's revenue base is generated through partnering and licensing strategies involving low-risk, fast to market products and commercialization partners worldwide. PharmaNova's current focus is on extraordinary value products in Women's Health and adjacent areas, including a non-hormonal treatment for menopausal hot flashes, anti-viral agents and cancer chemotherapeutics.

Orient Europharma Co. Ltd., ( ' http://www.OEP.com.tw ' ) is an international publicly traded pharmaceutical and nutritional company based in Taipei, Taiwan, R.O.C. traded over the counter under symbol "OEP." OEP specializes in research and marketing of innovative, niche-oriented pharmaceuticals, with a strong franchise in oncology, nutritional and food supplements, dermo-cosmetics and consumer healthcare products. OEP has a well-established marketing base in numerous Asia-Pacific countries with subsidiaries in Singapore, Malaysia, Hong Kong, Philippines and China, and it is poised for significant growth.

For more information, please click here

Contacts:
Rodney Brown
PharmaNova, Inc.
1-585-214-0590

Copyright © EWORLDWIRE™

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Northwestern scientists develop first liquid nanolaser: Technology could lead to new way of doing 'lab on a chip' medical diagnostics April 25th, 2015

Nanotech-enabled moisturizer speeds healing of diabetic skin wounds: Spherical nucleic acids silence gene that interferes with wound healing April 24th, 2015

Fast and accurate 3-D imaging technique to track optically trapped particles April 24th, 2015

A silver lining: UCSB researchers cradle silver nanoclusters inside synthetic DNA to create a programmed, tunable fluorescent array April 23rd, 2015

Announcements

New ASTM Standards Will Help Educate Present and Future Nanotechnology Workforces April 26th, 2015

Heat makes electrons’ spin in magnetic superconductors April 26th, 2015

QD Vision Wins 2015 Bronze Edison Award for Color IQ™ Quantum Dot Technology April 26th, 2015

SEFCU, SUNY Poly CNSE Announce Winning Student-Led Teams in the 6th Annual $500,000 New York Business Plan Competition April 25th, 2015

Alliances/Partnerships/Distributorships

How can you see an atom? (video) April 10th, 2015

FibeRio and VF Corporation Form Strategic Partnership to Lead the Apparel and Footwear Markets in Nanofiber Technology April 8th, 2015

UK National Graphene Institute Selects Bruker as Official Partner: World-Leading Graphene Research Facility Purchases Multiple Bruker AFMs April 7th, 2015

NXP and GLOBALFOUNDRIES Announce Production of 40nm Embedded Non-Volatile Memory Technology: Co-developed technology to leverage GLOBALFOUNDRIES 40nm process technology platform March 24th, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project